EECP (Enhanced External Counterpulsation)
Enhanced external counterpulsation (EECP) is a noninvasive treatment used to treat coronary artery disease (partial or total blockage of heart arteries) and heart failure (a condition in which the heart cannot pump enough blood to meet the body's needs) patients.
Patients with the following conditions can use EECP:
- Angina or angina-equivalent symptoms, such as shortness of breath and/or fatigue
- Chronic heart failure
- Coronary artery disease with diabetes
- Coronary artery disease
- Ischemic or idiopathic cardiomyopathy
- Syndrome X or microvascular angina (small vessel disease)
- Unstable angina pectoris
Also, patients who are considered inoperable or at high risk are approved for EECP treatment.
With EECP, patients may experience fewer symptoms associated with coronary artery disease and heart failure. Individuals who receive EECP often, but not in every case, report an improvement in quality of life and in their exercise capacity.